ALEXIS LORINSKAS: Open Payments
NPI 1255618237 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 45 payments from 13 companies in 2025. Trend: 2023 $1,395 · 2024 $755 · 2025 $885
Food & beverage: $820Education: $65
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $252 |
| ABBVIE INC. | 9 | $171 |
| Organon LLC | 7 | $101 |
| UCB, Inc. | 4 | $98 |
| Janssen Biotech, Inc. | 1 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $30 |
| Incyte Corporation | 1 | $29 |
| Galderma Laboratories, L.P. | 1 | $29 |
| GENZYME CORPORATION | 1 | $21 |
Products named: OTEZLA, SKYRIZI, Bimzelx, VTAMA, TREMFYA, Sotyktu, OPZELURA, NEMLUVIO.
Industry payments across IL — which companies pay providers there.
